{"generated":"2026-08-28T16:42:09Z","content_changed":"2026-08-28T15:15:36Z","window_days":30,"count":294,"note":"Elke wijziging in de Lemmid Manager achter hartvaat.nl in de laatste 30 dagen; vergelijk updated met je vorige bezoek en herlees alleen wat veranderde.","changes":[{"updated":"2026-08-28T15:15:36Z","type":"article","id":"esc26-cvd-ckd","title":"Hart en nier in één richtlijn: waarom de ESC ze samen behandelt","url":"https://hartvaat.nl/2026/08/10/hart-en-nier-in-een-richtlijn-waarom-de-esc-ze-samen-behandelt/","new":true},{"updated":"2026-08-28T15:15:23Z","type":"congress","id":"esc-2026","title":"ESC Congress 2026 — Live vanuit München","url":"https://hartvaat.nl/congres/esc-2026/","new":true},{"updated":"2026-08-28T15:15:18Z","type":"article","id":"esc26-live-revalidatie-richtlijn","title":"Eerste ESC-richtlijn hartrevalidatie: multidisciplinair, ook thuis en digitaal, en voor veel meer patiënten dan alleen na een infarct","url":"https://hartvaat.nl/2026/08/28/eerste-esc-richtlijn-hartrevalidatie-multidisciplinair-ook-thuis-en-digitaal-en-/","new":true},{"updated":"2026-08-28T15:15:17Z","type":"article","id":"esc26-live-mi-definitie","title":"Vijfde universele definitie van het myocardinfarct: de typenummers verdwijnen, voortaan primair, secundair of procedureel infarct","url":"https://hartvaat.nl/2026/08/28/vijfde-universele-definitie-van-het-myocardinfarct-de-typenummers-verdwijnen-voo/","new":true},{"updated":"2026-08-28T15:15:17Z","type":"article","id":"esc26-live-cmr-guide","title":"CMR GUIDE: ICD bij littekenweefsel en LVEF 36 tot 50 procent mist het primaire eindpunt, maar halveert plotse hartdood en helpt vooral onder de 70","url":"https://hartvaat.nl/2026/08/28/cmr-guide-icd-bij-littekenweefsel-en-lvef-36-tot-50-procent-mist-het-primaire-ei/","new":true},{"updated":"2026-08-28T15:15:17Z","type":"article","id":"esc26-live-poet-ii","title":"POET-II: responsgestuurde antibioticaduur bij linkszijdige endocarditis scheelt twee weken en is niet-inferieur, maar geeft meer recidieven","url":"https://hartvaat.nl/2026/08/28/poet-ii-responsgestuurde-antibioticaduur-bij-linkszijdige-endocarditis-scheelt-t/","new":true},{"updated":"2026-08-28T15:15:17Z","type":"article","id":"esc26-live-cvd-ckd-richtlijn","title":"Nieuwe ESC-richtlijn hart en nier 2026: eGFR en albuminurie bij elke hartpatiënt, SGLT2-remmer ongeacht ejectiefractie, en een Groningse voorzitter","url":"https://hartvaat.nl/2026/08/28/nieuwe-esc-richtlijn-hart-en-nier-2026-egfr-en-albuminurie-bij-elke-hartpatient-/","new":true},{"updated":"2026-08-28T15:15:17Z","type":"article","id":"esc26-live-single-af","title":"SINGLE-AF: DOAC beschermt patiënten met atriumfibrilleren en één risicofactor, zonder meer ernstige bloedingen","url":"https://hartvaat.nl/2026/08/28/single-af-doac-beschermt-patienten-met-atriumfibrilleren-en-een-risicofactor-zon/","new":true},{"updated":"2026-08-28T15:15:16Z","type":"article","id":"esc26-live-cardio-ttransform","title":"CARDIO-TTRansform: eplontersen mist het primaire eindpunt bij ATTR-cardiomyopathie, alleen zonder stabilisator een nominaal signaal","url":"https://hartvaat.nl/2026/08/28/cardio-ttransform-eplontersen-mist-het-primaire-eindpunt-bij-attr-cardiomyopathi/","new":true},{"updated":"2026-08-28T15:15:16Z","type":"article","id":"esc26-live-hf-richtlijn","title":"Nieuwe ESC-hartfalenrichtlijn 2026: twee fenotypes in plaats van drie, MRA voor iedereen, stadia A tot D en semaglutide bij HFpEF met obesitas","url":"https://hartvaat.nl/2026/08/28/nieuwe-esc-hartfalenrichtlijn-2026-twee-fenotypes-in-plaats-van-drie-mra-voor-ie/","new":true},{"updated":"2026-08-28T15:15:16Z","type":"article","id":"esc26-live-acacia-hcm","title":"ACACIA-HCM: aficamten verbetert symptomen en inspanningscapaciteit bij niet-obstructieve HCM, de eerste positieve trial ooit in deze groep","url":"https://hartvaat.nl/2026/08/28/acacia-hcm-aficamten-verbetert-symptomen-en-inspanningscapaciteit-bij-niet-obstr/","new":true},{"updated":"2026-08-27T05:31:08Z","type":"event","id":"vasculair-spreekuur-amsterdam","title":"Vasculair Spreekuur 2026: Regio Amsterdam","url":"https://hartvaat.nl/agenda/","new":false},{"updated":"2026-08-27T05:31:08Z","type":"event","id":"nvvc-voorjaarscongres","title":"NVVC Voorjaarscongres 2026","url":"https://hartvaat.nl/agenda/","new":false},{"updated":"2026-08-27T05:31:08Z","type":"event","id":"esc-guideline-update-utrecht","title":"A Closer Look at the 2025 ESC Guideline Updates: Regio Utrecht","url":"https://hartvaat.nl/agenda/","new":false},{"updated":"2026-08-27T05:31:08Z","type":"event","id":"eas-paediatric-fh-symposium-2026","title":"EAS Paediatric FH Symposium","url":"https://hartvaat.nl/agenda/","new":false},{"updated":"2026-08-27T05:31:08Z","type":"event","id":"esc-guideline-update-nijmegen","title":"A Closer Look at the 2025 ESC Guideline Updates: Regio Nijmegen","url":"https://hartvaat.nl/agenda/","new":false},{"updated":"2026-08-27T05:31:08Z","type":"event","id":"esc-guideline-update-denhaag","title":"A Closer Look at the 2025 ESC Guideline Updates: Regio Den Haag / Rotterdam / Leiden","url":"https://hartvaat.nl/agenda/","new":false},{"updated":"2026-08-27T05:31:08Z","type":"event","id":"dres-cathlab","title":"DRES & Cathlab Symposium 2026","url":"https://hartvaat.nl/agenda/","new":false},{"updated":"2026-08-27T05:31:08Z","type":"event","id":"esc-congress-2027","title":"ESC Congress 2027","url":"https://hartvaat.nl/agenda/","new":false},{"updated":"2026-08-27T05:31:08Z","type":"event","id":"aha-2027","title":"AHA Scientific Sessions 2027","url":"https://hartvaat.nl/agenda/","new":false},{"updated":"2026-08-27T05:31:07Z","type":"event","id":"vasculair-spreekuur-nijmegen","title":"Vasculair Spreekuur 2026: Regio Nijmegen","url":"https://hartvaat.nl/agenda/","new":false},{"updated":"2026-08-27T05:29:06Z","type":"event","id":"66378","title":"TCT 2026","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:06Z","type":"event","id":"66379","title":"AHA Scientific Sessions 2026","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:06Z","type":"event","id":"66380","title":"EACVI 2026 (EuroEcho, EuroCMR, ICNC-CT)","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:06Z","type":"event","id":"66377","title":"De Haagse Cursus Echocardiografie 2027","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:06Z","type":"event","id":"66381","title":"ESC Acute CardioVascular Care 2027","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:06Z","type":"event","id":"66382","title":"EHRA 2027","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:06Z","type":"event","id":"66383","title":"ESC Preventive Cardiology 2027","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:06Z","type":"event","id":"66384","title":"EuroPCR 2027","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:06Z","type":"event","id":"66385","title":"Heart Failure 2027","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:05Z","type":"event","id":"66371","title":"Lipid management, diabetes type 2 and beyond: regio Amsterdam","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:05Z","type":"event","id":"66374","title":"Basiscursus Electrocardiografie 2026-II","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:05Z","type":"event","id":"66368","title":"7e CarVascGer Congres","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:05Z","type":"event","id":"66369","title":"CVRM 2.0: Van Richtlijn naar Resultaat","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:05Z","type":"event","id":"66372","title":"Lipid management, diabetes type 2 and beyond: regio Groningen","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:05Z","type":"event","id":"66373","title":"EXPERT-PE Conference 2026","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:05Z","type":"event","id":"66370","title":"Jaarupdate Cardiovasculaire Preventie 2026","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:05Z","type":"event","id":"66375","title":"Multidisciplinair Hartfalen Congres 2027","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:05Z","type":"event","id":"66376","title":"Nationaal Hypertensie Congres 2027","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:04Z","type":"event","id":"66366","title":"HartVaatHAG Congres 2026: Dapper beslissen in de jungle van CVRM","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:04Z","type":"event","id":"66364","title":"NHN Symposium 2026: Hartzorg zonder ruis","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:04Z","type":"event","id":"66365","title":"NVVC-NVT Najaarscongres 2026","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:29:04Z","type":"event","id":"66367","title":"Jaarcongres Nederlands Vasculair Forum 2026","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:28:28Z","type":"event","id":"echo-hartfalen-avond-sep","title":"3e Echo/Hartfalen Avond 2026","url":"https://hartvaat.nl/agenda/","new":false},{"updated":"2026-08-27T05:28:28Z","type":"event","id":"echo-hartfalen-avond-nov","title":"4e Echo/Hartfalen Avond 2026","url":"https://hartvaat.nl/agenda/","new":false},{"updated":"2026-08-27T05:28:26Z","type":"organiser","id":"66362","title":"CRF","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:28:26Z","type":"organiser","id":"66363","title":"PCR","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:28:25Z","type":"organiser","id":"66361","title":"HartVaatHAG","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:28:25Z","type":"organiser","id":"66360","title":"Nederlands Hart Netwerk","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-08-27T05:20:40Z","type":"article","id":"esc26-nhcm","title":"Niet-obstructieve HCM: waarom ACACIA-HCM de eerste echte kans op een medicijn is","url":"https://hartvaat.nl/2026/08/10/niet-obstructieve-hcm-waarom-acacia-hcm-de-eerste-echte-kans-op-een-medicijn-is/","new":true},{"updated":"2026-08-27T05:20:40Z","type":"article","id":"esc26-attr","title":"ATTR-cardiomyopathie aan de vooravond van CARDIO-TTRansform","url":"https://hartvaat.nl/2026/08/10/attr-cardiomyopathie-aan-de-vooravond-van-cardio-ttransform/","new":true},{"updated":"2026-08-26T04:17:10Z","type":"podcastepisode","id":"66335","title":"#47: Geen vlees, wel kippenvel","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-08-24T03:35:14Z","type":"vacancy","id":"8f03856aafe3","title":"Hartfunctielaborant echocardiografie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:13Z","type":"vacancy","id":"3f7835e30d45","title":"MHV Traineeship Interventie Cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:13Z","type":"vacancy","id":"de58d5101c26","title":"Vacature — Medisch secretarieel medewerker Nefrologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:13Z","type":"vacancy","id":"1ed648a00720","title":"Verpleegkundig specialist cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:13Z","type":"vacancy","id":"d7894301e545","title":"Arts-onderzoeker Interventie Cardiologie","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-08-24T03:35:12Z","type":"vacancy","id":"a37c0d79c819","title":"(Senior) Verpleegkundige in opleiding tot CCU-verpleegkundige","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:12Z","type":"vacancy","id":"3816aac39923","title":"Kom werken als Eerste hart-long hulp verpleegkundige bij Noordwest","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:12Z","type":"vacancy","id":"8aebed94c751","title":"Verpleegkundig Specialist In Opleiding Vasculaire Interne Geneeskunde","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:12Z","type":"vacancy","id":"39aa6e12ccd2","title":"Ikazia ziekenhuis | Verpleegkundige Cardiologie","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-08-24T03:35:12Z","type":"vacancy","id":"1d993878cc6e","title":"Ikazia ziekenhuis | Vasculair Diagnostisch Laborant","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-08-24T03:35:11Z","type":"vacancy","id":"f2cf8c61b47c","title":"Vacature: Arts promovendus Structurele Hartziekten","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:10Z","type":"vacancy","id":"d4bf55820575","title":"Fellow – Cardiothoracale en Vasculaire Anesthesiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:10Z","type":"vacancy","id":"ea4b27297e41","title":"ANIOS Cardiothoracale chirurgie - fulltime","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:10Z","type":"vacancy","id":"4dd88f8c831b","title":"Chef de Clinique - Algemeen Cardioloog parttime-fulltime","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:10Z","type":"vacancy","id":"7e343832d173","title":"Vaatchirurg - Fulltime","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:10Z","type":"vacancy","id":"14067b4819b3","title":"Chef de Clinique Cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:10Z","type":"vacancy","id":"593d6428e8eb","title":"Medewerker interventiecardiologie - Opleidingsplaats","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:10Z","type":"vacancy","id":"481698b2025f","title":"Teamhoofd Kliniek Hart","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:10Z","type":"vacancy","id":"2b2d54b04434","title":"Echocardiografist","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-24T03:35:09Z","type":"vacancy","id":"5abae954de00","title":"Promovendus interventie MRI | Cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-21T01:42:07Z","type":"article","id":"5abf53b54879","title":"Deep learning op mobiele ECG voorspelt atriumfibrilleren binnen 30 dagen","url":"https://hartvaat.nl/2026/08/20/deep-learning-op-mobiele-ecg-voorspelt-atriumfibrilleren-binnen-30-dagen/","new":true},{"updated":"2026-08-21T01:38:31Z","type":"article","id":"5ab6489b60c3","title":"Risicofactoren voor vroege, tussen- en late hartfalenheropnames na ontslag","url":"https://hartvaat.nl/2026/08/20/risicofactoren-voor-vroege-tussen-en-late-hartfalenheropnames-na-ontslag/","new":true},{"updated":"2026-08-21T01:34:49Z","type":"article","id":"0b1c0b70e8a8","title":"Long COVID verhoogt risico op hart-, nier- en longcomplicaties — TriNetX-cohort","url":"https://hartvaat.nl/2026/08/20/long-covid-verhoogt-risico-op-hart-nier-en-longcomplicaties-trinetx-cohort/","new":true},{"updated":"2026-08-21T01:31:57Z","type":"article","id":"9b7b49d4bf8e","title":"Ouderlijke obesitas verhoogt cardiorenale risico's bij nakomelingen — review","url":"https://hartvaat.nl/2026/08/20/ouderlijke-obesitas-verhoogt-cardiorenale-risico-s-bij-nakomelingen-review/","new":true},{"updated":"2026-08-21T01:27:52Z","type":"article","id":"a4de32c788b1","title":"Aangetaste tubulaire secretiecapaciteit verhoogt cardiovasculaire sterfte — HUNT-studie","url":"https://hartvaat.nl/2026/08/20/aangetaste-tubulaire-secretiecapaciteit-verhoogt-cardiovasculaire-sterfte-hunt-s/","new":true},{"updated":"2026-08-21T01:19:27Z","type":"article","id":"fa6d3b15179a","title":"Clopidogrel superieur aan aspirine na PCI — 10-jaar HOST-EXAM","url":"https://hartvaat.nl/2026/08/22/clopidogrel-superieur-aan-aspirine-na-pci-10-jaar-host-exam/","new":true},{"updated":"2026-08-21T00:57:10Z","type":"article","id":"aa7f427c644c","title":"Verhoogd 10-jaar ASCVD-risico gekoppeld aan linkerventrikelhypertrofie bij hypertensiepatiënten","url":"https://hartvaat.nl/2026/09/01/verhoogd-10-jaar-ascvd-risico-gekoppeld-aan-linkerventrikelhypertrofie-bij-hyper/","new":true},{"updated":"2026-08-21T00:54:03Z","type":"article","id":"f9509e699108","title":"LDL-C-reductie ≥50% verlaagt risico op secundaire cardiovasculaire gebeurtenissen na ischemische stroke","url":"https://hartvaat.nl/2026/09/22/ldl-c-reductie-50-verlaagt-risico-op-secundaire-cardiovasculaire-gebeurtenissen-/","new":true},{"updated":"2026-08-21T00:50:59Z","type":"article","id":"c5a71cfa9a8c","title":"Cardiale amyloidose komt bij 9% van TAVI-patiënten voor — ongeacht stromingspatroon","url":"https://hartvaat.nl/2026/10/01/cardiale-amyloidose-komt-bij-9-van-tavi-patienten-voor-ongeacht-stromingspatroon/","new":true},{"updated":"2026-08-21T00:47:53Z","type":"article","id":"bd46fe688be5","title":"MASLD verhoogt sterfte- en CV-risico, onafhankelijk van lipoproteïne(a)","url":"https://hartvaat.nl/2026/10/01/masld-verhoogt-sterfte-en-cv-risico-onafhankelijk-van-lipoproteine-a/","new":true},{"updated":"2026-08-19T01:26:44Z","type":"article","id":"8b67fccf2b2d","title":"Finerenone blijft effectief bij CKM-patiënten met kankeranamnese — FINE-HEART","url":"https://hartvaat.nl/2026/08/18/finerenone-blijft-effectief-bij-ckm-patienten-met-kankeranamnese-fine-heart/","new":true},{"updated":"2026-08-19T01:22:20Z","type":"article","id":"62f7193f44e4","title":"Tafamidis bij ATTR-cardiomyopathie kosteffectiviteit onder de maat in vier Europese landen","url":"https://hartvaat.nl/2026/08/18/tafamidis-bij-attr-cardiomyopathie-kosteffectiviteit-onder-de-maat-in-vier-europ/","new":true},{"updated":"2026-08-19T01:15:25Z","type":"article","id":"bb9fb839e3dc","title":"Echocardiografie overschatte drukgradiënten na TAV-in-TAV met ballon-expandable kleppen","url":"https://hartvaat.nl/2026/08/18/echocardiografie-overschatte-drukgradienten-na-tav-in-tav-met-ballon-expandable-/","new":true},{"updated":"2026-08-19T01:11:34Z","type":"article","id":"2608955c262b","title":"Sheath-to-artery ratio voorspelt access-site complicaties bij femoraal ingrijpen","url":"https://hartvaat.nl/2026/08/18/sheath-to-artery-ratio-voorspelt-access-site-complicaties-bij-femoraal-ingrijpen/","new":true},{"updated":"2026-08-19T01:07:59Z","type":"article","id":"7ca00e216ae0","title":"Semaglutide verlaagt hsCRP en ontstekingsactiviteit bij ASCVD-patiënten met overgewicht — SELECT","url":"https://hartvaat.nl/2026/08/18/semaglutide-verlaagt-hscrp-en-ontstekingsactiviteit-bij-ascvd-patienten-met-over/","new":true},{"updated":"2026-08-19T01:04:12Z","type":"article","id":"ee7bb936618f","title":"GLP-1-agonisten verlagen cardiovasculaire risico’s bij diabetes en obesitas — overzicht","url":"https://hartvaat.nl/2026/08/18/glp-1-agonisten-verlagen-cardiovasculaire-risicos-bij-diabetes-en-obesitas-overz/","new":true},{"updated":"2026-08-19T01:01:19Z","type":"article","id":"b26440917450","title":"C-MIC-apparaat vermindert hartfalen-ernst onafhankelijk van GDMT-aanpassingen — C-MIC II","url":"https://hartvaat.nl/2026/08/18/c-mic-apparaat-vermindert-hartfalen-ernst-onafhankelijk-van-gdmt-aanpassingen-c-/","new":true},{"updated":"2026-08-19T00:55:54Z","type":"article","id":"327a9109fae5","title":"FGF23-niveaus correleren met vaatcalcificatie en CV-risico bij peritonealdialysepatiënten","url":"https://hartvaat.nl/2026/08/18/fgf23-niveaus-correleren-met-vaatcalcificatie-en-cv-risico-bij-peritonealdialyse/","new":true},{"updated":"2026-08-19T00:51:16Z","type":"article","id":"d1442dc3232f","title":"HIF-stabilisatoren als orale alternatief voor ESAs bij anemie bij chronische nierziekte","url":"https://hartvaat.nl/2026/08/18/hif-stabilisatoren-als-orale-alternatief-voor-esas-bij-anemie-bij-chronische-nie/","new":true},{"updated":"2026-08-19T00:48:20Z","type":"article","id":"43b8dcf7203e","title":"Combinatietherapie bij T2DM en chronische nierziekte — evidence naar praktijk","url":"https://hartvaat.nl/2026/08/18/combinatietherapie-bij-t2dm-en-chronische-nierziekte-evidence-naar-praktijk/","new":true},{"updated":"2026-08-17T03:35:42Z","type":"vacancy","id":"fb56dbbf49a3","title":"CCU verpleegkundige (in opleiding)","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-17T03:35:42Z","type":"vacancy","id":"2b6ee91bc930","title":"Vacature — ANIOS Cardiologie","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-08-17T03:35:42Z","type":"vacancy","id":"8404af54300b","title":"Teamleider Hartbewaking en Eerste hart hulp","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-08-17T03:35:41Z","type":"vacancy","id":"b298bfaed709","title":"Physician Assistant in opleiding Vasculaire Interne Geneeskunde","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-17T03:35:41Z","type":"vacancy","id":"b935d49f3bdd","title":"Hartfunctielaborant met specialisatie echocardiografie en ambulante ecg-monitoring","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-17T03:35:41Z","type":"vacancy","id":"583dc48886d4","title":"Ikazia ziekenhuis | Doktersassistent Cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-17T03:35:40Z","type":"vacancy","id":"55388c29a406","title":"Medisch assistent Echografie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-17T03:35:40Z","type":"vacancy","id":"7f8d83e113fc","title":"Physician Assistant Hartcentrum - parttime","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-17T03:35:40Z","type":"vacancy","id":"46ccf431b64c","title":"Dialyseverpleegkundige (in opleiding) Bernhoven","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-17T03:35:39Z","type":"vacancy","id":"cb8fe229ca0f","title":"PhD AI-based cardiovascular image analysis and modeling","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-17T03:35:39Z","type":"vacancy","id":"acdc86b15518","title":"Verpleegkundige Cardiologie & Cardiothoracale chirurgie - Amphia","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-17T03:35:38Z","type":"vacancy","id":"be4b119b0b4d","title":"Doseeradviseur Trombosezorg Accureon","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-17T01:23:00Z","type":"article","id":"07d788a3ca2d","title":"Geautomatiseerde lipidenmonitoring en risicoclassificatie in de huisartspraktijk — real-world studie","url":"https://hartvaat.nl/2026/08/15/geautomatiseerde-lipidenmonitoring-en-risicoclassificatie-in-de-huisartspraktijk/","new":true},{"updated":"2026-08-17T01:17:23Z","type":"article","id":"24adbbb10f40","title":"FIB-4 en FNI duiden op cardiorenale en metabole belasting bij T2DM en MASLD","url":"https://hartvaat.nl/2026/08/15/fib-4-en-fni-duiden-op-cardiorenale-en-metabole-belasting-bij-t2dm-en-masld/","new":true},{"updated":"2026-08-17T01:13:13Z","type":"article","id":"f5e6701686fc","title":"Injecteerbare lipidendalers bij gevorderde chronische nierziekte en dialyse — narratieve review","url":"https://hartvaat.nl/2026/08/15/injecteerbare-lipidendalers-bij-gevorderde-chronische-nierziekte-en-dialyse-narr/","new":true},{"updated":"2026-08-17T01:09:47Z","type":"article","id":"8fa4c2348db4","title":"Tirzepatide verlaagt hypertensierisico maar verhoogt hypotensie — meta-analyse","url":"https://hartvaat.nl/2026/08/15/tirzepatide-verlaagt-hypertensierisico-maar-verhoogt-hypotensie-meta-analyse/","new":true},{"updated":"2026-08-17T01:03:05Z","type":"article","id":"b277517fda21","title":"PM2.5-blootstelling versnelt daling van eGFR bij volwassenen","url":"https://hartvaat.nl/2026/09/01/pm2-5-blootstelling-versnelt-daling-van-egfr-bij-volwassenen/","new":true},{"updated":"2026-08-17T00:58:57Z","type":"article","id":"962816aec390","title":"Vrouwen met perifeer arterieel vaatlijden presenteren later met meer distale ziekte — overzicht","url":"https://hartvaat.nl/2026/09/01/vrouwen-met-perifeer-arterieel-vaatlijden-presenteren-later-met-meer-distale-zie/","new":true},{"updated":"2026-08-17T00:55:00Z","type":"article","id":"48d9e3dab1ab","title":"Cardiale CT als standaard in de electrophysiologie — planning en veiligheid bij AF-ablatie en CIED-behandeling","url":"https://hartvaat.nl/2026/10/01/cardiale-ct-als-standaard-in-de-electrophysiologie-planning-en-veiligheid-bij-af/","new":true},{"updated":"2026-08-17T00:51:52Z","type":"article","id":"467bc22cee44","title":"Hepcidine heeft beperkte waarde voor het sturen van anemietherapie bij CKD","url":"https://hartvaat.nl/2026/10/01/hepcidine-heeft-beperkte-waarde-voor-het-sturen-van-anemietherapie-bij-ckd/","new":true},{"updated":"2026-08-17T00:49:26Z","type":"article","id":"72a1ba04d12c","title":"Risicotool identificeert ATTR-cardiomyopathie bij patiënten met carpaaltunnelsyndroom","url":"https://hartvaat.nl/2026/11/01/risicotool-identificeert-attr-cardiomyopathie-bij-patienten-met-carpaaltunnelsyn/","new":true},{"updated":"2026-08-17T00:46:15Z","type":"article","id":"68d2e865f70b","title":"Kort slapen (<6 uur) verhoogt kans op hypertensie bij ouderen — CLHLS","url":"https://hartvaat.nl/2026/12/01/kort-slapen-6-uur-verhoogt-kans-op-hypertensie-bij-ouderen-clhls/","new":true},{"updated":"2026-08-15T01:33:49Z","type":"article","id":"e7fd2a2fa28b","title":"Hogere HU-drempels voegen geen waarde toe aan CT-calciumscoring voor aortaklepstenose","url":"https://hartvaat.nl/2026/08/14/hogere-hu-drempels-voegen-geen-waarde-toe-aan-ct-calciumscoring-voor-aortaklepst/","new":true},{"updated":"2026-08-15T01:27:58Z","type":"article","id":"291329581677","title":"Biotechnologie en AI veranderen precisielipidenmanagement — van PCSK9 tot CRISPR","url":"https://hartvaat.nl/2026/08/14/biotechnologie-en-ai-veranderen-precisielipidenmanagement-van-pcsk9-tot-crispr/","new":true},{"updated":"2026-08-15T01:22:38Z","type":"article","id":"331929812489","title":"Dapagliflozin verlaagt serum-Klotho bij dialysepatiënten zonder effect op botbiomarkers of fracturen — post-hoc RCT","url":"https://hartvaat.nl/2026/08/14/dapagliflozin-verlaagt-serum-klotho-bij-dialysepatienten-zonder-effect-op-botbio/","new":true},{"updated":"2026-08-15T01:17:28Z","type":"article","id":"6e50d85f984f","title":"Kaliumbinders ondersteunen RAASi-gebruik bij CKD, maar terugkeer van hyperkaliëmie versnelt nierfunctieverlies","url":"https://hartvaat.nl/2026/08/14/kaliumbinders-ondersteunen-raasi-gebruik-bij-ckd-maar-terugkeer-van-hyperkaliemi/","new":true},{"updated":"2026-08-15T01:14:30Z","type":"article","id":"49cf19811014","title":"CRP en albuminurie duiden op hoog risico op herhalende hart- en vaatziekten bij chronische nierziekte — KNOW-CKD","url":"https://hartvaat.nl/2026/08/14/crp-en-albuminurie-duiden-op-hoog-risico-op-herhalende-hart-en-vaatziekten-bij-c/","new":true},{"updated":"2026-08-15T01:08:23Z","type":"article","id":"46a86f33b7d7","title":"Infectie is belangrijkste doodsoorzaak bij dialysepatiënten — retrospectieve analyse","url":"https://hartvaat.nl/2026/08/14/infectie-is-belangrijkste-doodsoorzaak-bij-dialysepatienten-retrospectieve-analy/","new":true},{"updated":"2026-08-15T01:05:02Z","type":"article","id":"8962d45e297d","title":"Vereenvoudigd CRT-systeem zonder atriale pacing niet slechter dan conventioneel — CRT-NEXT","url":"https://hartvaat.nl/2026/08/14/vereenvoudigd-crt-systeem-zonder-atriale-pacing-niet-slechter-dan-conventioneel-/","new":true},{"updated":"2026-08-15T00:57:34Z","type":"article","id":"b68d8e419204","title":"SGLT2-remmers geassocieerd met lagere sterfte bij ATTR-cardiomyopathie — meta-analyse","url":"https://hartvaat.nl/2026/10/01/sglt2-remmers-geassocieerd-met-lagere-sterfte-bij-attr-cardiomyopathie-meta-anal/","new":true},{"updated":"2026-08-15T00:52:59Z","type":"article","id":"6d8b3789e522","title":"Voorgebruik van opioïden verhoogt sterfte en ziekenhuisopnames na TAVI — Deens cohort","url":"https://hartvaat.nl/2026/10/01/voorgebruik-van-opioiden-verhoogt-sterfte-en-ziekenhuisopnames-na-tavi-deens-coh/","new":true},{"updated":"2026-08-15T00:48:20Z","type":"article","id":"6318df214e86","title":"Verhoogde bloeddruk bij jonge volwassenen verdubbelt sterftekans — NHANES-cohort","url":"https://hartvaat.nl/2026/12/01/verhoogde-bloeddruk-bij-jonge-volwassenen-verdubbelt-sterftekans-nhanes-cohort/","new":true},{"updated":"2026-08-13T01:42:28Z","type":"article","id":"97c5853ff1d4","title":"Clonale hematopoïese voorspelt nierfunctievermindering en sterfte bij cytopenie met chronische nierziekte","url":"https://hartvaat.nl/2026/08/12/clonale-hematopoiese-voorspelt-nierfunctievermindering-en-sterfte-bij-cytopenie-/","new":true},{"updated":"2026-08-13T01:37:07Z","type":"article","id":"c3eefff6acb2","title":"Romosozumab vermindert wervelfracturen en MACE bij osteoporose met chronische nierziekte — TriNetX-cohort","url":"https://hartvaat.nl/2026/08/12/romosozumab-vermindert-wervelfracturen-en-mace-bij-osteoporose-met-chronische-ni/","new":true},{"updated":"2026-08-13T01:32:20Z","type":"article","id":"3abb43a3c3a5","title":"IVF-gebruik niet geassocieerd met hart- en vaatziekten — behalve herseninfarct","url":"https://hartvaat.nl/2026/08/12/ivf-gebruik-niet-geassocieerd-met-hart-en-vaatziekten-behalve-herseninfarct/","new":true},{"updated":"2026-08-13T01:25:26Z","type":"article","id":"c633c1fb00b5","title":"HDL-eiwitten bepalen CVD- en ontstekingsrisico — onafhankelijk van HDL-C","url":"https://hartvaat.nl/2026/08/13/hdl-eiwitten-bepalen-cvd-en-ontstekingsrisico-onafhankelijk-van-hdl-c/","new":true},{"updated":"2026-08-13T01:17:51Z","type":"article","id":"db79f13475f0","title":"Metformin verlaagt risico op buikaorta-aneurysma — MR- en cohortanalyse","url":"https://hartvaat.nl/2026/09/01/metformin-verlaagt-risico-op-buikaorta-aneurysma-mr-en-cohortanalyse/","new":true},{"updated":"2026-08-13T01:12:35Z","type":"article","id":"b99ab4bae3eb","title":"Pre-existent PFO of ASD verhoogt risico op recidief en stroke na ablatie bij atriumfibrilleren","url":"https://hartvaat.nl/2026/09/01/pre-existent-pfo-of-asd-verhoogt-risico-op-recidief-en-stroke-na-ablatie-bij-atr/","new":true},{"updated":"2026-08-13T01:03:54Z","type":"article","id":"5f8fa609f50f","title":"Perioperatieve opioiden bij hartfalen: lokale cardiale routes en klinische risico’s","url":"https://hartvaat.nl/2026/09/01/perioperatieve-opioiden-bij-hartfalen-lokale-cardiale-routes-en-klinische-risico/","new":true},{"updated":"2026-08-13T00:57:59Z","type":"article","id":"8b203d990267","title":"Gepersonaliseerde bloeddrukregeling tijdens thrombectomie verbetert functionele uitkomst niet — DETERMINE","url":"https://hartvaat.nl/2026/09/08/gepersonaliseerde-bloeddrukregeling-tijdens-thrombectomie-verbetert-functionele-/","new":true},{"updated":"2026-08-13T00:52:09Z","type":"article","id":"fa7a75a687a6","title":"HIGS-score voorspelt pacemaker-implantatie en sterfte na TAVI","url":"https://hartvaat.nl/2026/12/01/higs-score-voorspelt-pacemaker-implantatie-en-sterfte-na-tavi/","new":true},{"updated":"2026-08-13T00:47:22Z","type":"article","id":"bf203669ae6c","title":"Antitrombotica veilig bij incidentele ongescheurde intracraniële aneurysma’s na ischemisch beroerte","url":"https://hartvaat.nl/2026/12/01/antitrombotica-veilig-bij-incidentele-ongescheurde-intracraniele-aneurysmas-na-i/","new":true},{"updated":"2026-08-12T04:17:11Z","type":"podcastepisode","id":"60721","title":"#46: De unieke verbinding tussen je hart & je brein","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-08-12T04:17:10Z","type":"podcastepisode","id":"60720","title":"Journal editorial: Decision curve analysis and the incremental value of cardiac MRI in transthyretin cardiac amyloidosis","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-08-12T04:17:10Z","type":"podcastepisode","id":"60719","title":"Journal editorial : Aortic valve calcification in type 2 diabetes: the heavy weight of comorbidities","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-08-11T01:24:19Z","type":"article","id":"fbf607852598","title":"Urine-albumine en natrium hebben prognostische waarde bij hartfalen — experimentele biomarkers nog onvoldoende onderbouwd","url":"https://hartvaat.nl/2026/08/10/urine-albumine-en-natrium-hebben-prognostische-waarde-bij-hartfalen-experimentel/","new":true},{"updated":"2026-08-11T01:20:49Z","type":"article","id":"7f5af9e720e8","title":"Voedingspatronen en macronutriëntenvervanging verlagen triglyceriden bij hypertriglyceridemie","url":"https://hartvaat.nl/2026/08/10/voedingspatronen-en-macronutrientenvervanging-verlagen-triglyceriden-bij-hypertr/","new":true},{"updated":"2026-08-11T01:15:33Z","type":"article","id":"64311db3d18a","title":"Anemie verergert mortaliteit en hartfalenheropnames na TAVR bij patiënten boven de 80 jaar","url":"https://hartvaat.nl/2026/09/01/anemie-verergert-mortaliteit-en-hartfalenheropnames-na-tavr-bij-patienten-boven-/","new":true},{"updated":"2026-08-11T01:11:17Z","type":"article","id":"f0cd8f93ab87","title":"Posteriorcirculatie-infarcten na doorbraakstroke op anticoagulantia duiden op slechtere prognose","url":"https://hartvaat.nl/2026/10/15/posteriorcirculatie-infarcten-na-doorbraakstroke-op-anticoagulantia-duiden-op-sl/","new":true},{"updated":"2026-08-11T01:07:04Z","type":"article","id":"a3fb55576706","title":"Vroege bloeddrukverlaging bij acute ischemische stroke verbetert functioneel herstel niet — meta-analyse","url":"https://hartvaat.nl/2026/10/15/vroege-bloeddrukverlaging-bij-acute-ischemische-stroke-verbetert-functioneel-her/","new":true},{"updated":"2026-08-11T00:58:55Z","type":"article","id":"1c021f5785d8","title":"RAS-remmers verlagen risico op nieuwe CKD bij diabetes type 2 met behoudende nierfunctie","url":"https://hartvaat.nl/2026/12/01/ras-remmers-verlagen-risico-op-nieuwe-ckd-bij-diabetes-type-2-met-behoudende-nie/","new":true},{"updated":"2026-08-11T00:54:42Z","type":"article","id":"bcbfa7cf81fb","title":"Positieve levensoriëntatie en bloeddruk bij ouderen: nauwelijks klinisch relevant verband — TUVA/UTUVA","url":"https://hartvaat.nl/2026/12/01/positieve-levensorientatie-en-bloeddruk-bij-ouderen-nauwelijks-klinisch-relevant/","new":true},{"updated":"2026-08-11T00:51:53Z","type":"article","id":"9b5e12e2006a","title":"Lage richtlijnconformiteit en zorgcontinuïteit bij hypertensie in Uruguay","url":"https://hartvaat.nl/2026/12/01/lage-richtlijnconformiteit-en-zorgcontinuiteit-bij-hypertensie-in-uruguay/","new":true},{"updated":"2026-08-11T00:49:05Z","type":"article","id":"21679f9c93cb","title":"Optimale cardiometabole gezondheid tijdens zwangerschap verlaagt risico op complicaties","url":"https://hartvaat.nl/2026/12/01/optimale-cardiometabole-gezondheid-tijdens-zwangerschap-verlaagt-risico-op-compl/","new":true},{"updated":"2026-08-11T00:45:48Z","type":"article","id":"810625634896","title":"Inter-enkel bloeddrukverschil correleert met microalbuminurie bij hypertensiepatiënten","url":"https://hartvaat.nl/2026/12/31/inter-enkel-bloeddrukverschil-correleert-met-microalbuminurie-bij-hypertensiepat/","new":true},{"updated":"2026-08-10T14:59:26Z","type":"videoprogram","id":"esc26-preview-trials-to-watch","title":"ESC 2026 Preview: Trials to Watch met Prof. Van Mieghem en Dr. Bertrand","url":"https://hartvaat.nl/video/esc26-preview-trials-to-watch/","new":true},{"updated":"2026-08-10T14:59:26Z","type":"videoepisode","id":"esc26-trials-to-watch-gesprek","title":"ESC 2026 Trials to Watch: het volledige gesprek","url":"https://hartvaat.nl/video/","new":true},{"updated":"2026-08-10T11:55:45Z","type":"article","id":"esc26-ai","title":"AI als co-piloot: wat het spotlightthema van ESC 2026 concreet betekent","url":"https://hartvaat.nl/2026/08/10/ai-als-co-piloot-wat-het-spotlightthema-van-esc-2026-concreet-betekent/","new":true},{"updated":"2026-08-10T11:55:45Z","type":"article","id":"esc26-factor-xi","title":"Factor XI-remming: de hypothese, de belofte en de les van LIBREXIA ACS","url":"https://hartvaat.nl/2026/08/10/factor-xi-remming-de-hypothese-de-belofte-en-de-les-van-librexia-acs/","new":true},{"updated":"2026-08-10T11:55:44Z","type":"article","id":"esc26-hf-richtlijn","title":"De nieuwe ESC-hartfalenrichtlijn: wat er op 28 augustus op tafel ligt","url":"https://hartvaat.nl/2026/08/10/de-nieuwe-esc-hartfalenrichtlijn-wat-er-op-28-augustus-op-tafel-ligt/","new":true},{"updated":"2026-08-10T11:55:44Z","type":"article","id":"esc26-staree","title":"Statines na je zeventigste: wat STAREE wel en niet gaat beantwoorden","url":"https://hartvaat.nl/2026/08/10/statines-na-je-zeventigste-wat-staree-wel-en-niet-gaat-beantwoorden/","new":true},{"updated":"2026-08-10T11:07:51Z","type":"article","id":"0d0a826a30f6","title":"HFpEF-fenotype duidt op hogere sterfte na TAVI bij laagstroom, laaggradient aortaklepstenose","url":"https://hartvaat.nl/2026/05/31/hfpef-fenotype-duidt-op-hogere-sterfte-na-tavi-bij-laagstroom-laaggradient-aorta/","new":false},{"updated":"2026-08-10T11:07:51Z","type":"article","id":"16341f39540b","title":"Afstand tot LDL-doelwaarde stuurt keuze lipiddalende therapie","url":"https://hartvaat.nl/2026/09/01/afstand-tot-ldl-doelwaarde-stuurt-keuze-lipiddalende-therapie/","new":false},{"updated":"2026-08-10T11:07:51Z","type":"article","id":"44651b83f9f9","title":"EuroTR-register: co-existente linkszijdige kleplek verhoogt sterfte na transcatheter-tricuspidalis-edge-to-edge repair","url":"https://hartvaat.nl/2026/05/05/eurotr-register-co-existente-linkszijdige-kleplek-verhoogt-sterfte-na-transcathe/","new":false},{"updated":"2026-08-10T11:07:51Z","type":"article","id":"aadc13fa7773","title":"Mavacamten in de praktijk: zwarte patiënten krijgen 55% minder vaak toegang — atriumfibrilleren voorspelt slechtere uitkomst","url":"https://hartvaat.nl/2026/05/05/mavacamten-in-de-praktijk-zwarte-patienten-krijgen-55-minder-vaak-toegang-atrium/","new":false},{"updated":"2026-08-10T11:07:51Z","type":"article","id":"a4cc12ed4162","title":"AI-Echo verslaat AI-ECG en klinische score voor diagnose cardiale amyloïdose (AUROC 0,93)","url":"https://hartvaat.nl/2026/05/13/ai-echo-verslaat-ai-ecg-en-klinische-score-voor-diagnose-cardiale-amyloidose-aur/","new":false},{"updated":"2026-08-10T11:07:51Z","type":"article","id":"a5dc206cd949","title":"Abelacimab versus rivaroxaban bij ouderen met AF: subanalyse","url":"https://hartvaat.nl/2026/03/01/abelacimab-versus-rivaroxaban-bij-ouderen-met-af-subanalyse/","new":false},{"updated":"2026-08-10T11:07:51Z","type":"article","id":"9e4709c9abe1","title":"ESC 0/1-uur versus 0/2- of 0/3-uur hoog-sensitief troponine-algoritmen bij verdenking acuut coronair syndroom","url":"https://hartvaat.nl/2025/01/01/esc-0-1-uur-versus-0-2-of-0-3-uur-hoog-sensitief-troponine-algoritmen-bij-verden/","new":false},{"updated":"2026-08-10T11:07:51Z","type":"article","id":"6c83ab4923a5","title":"PATHFINDER-trial: betere naleving van hartfalenrichtlijnen in de huisartsenpraktijk","url":"https://hartvaat.nl/2026/02/23/pathfinder-trial-betere-naleving-van-hartfalenrichtlijnen-in-de-huisartsenprakti/","new":false},{"updated":"2026-08-10T11:07:51Z","type":"article","id":"daf86bf00507","title":"Factor XI/XIa-remmers bij atriumfibrilleren: dosisrespons, werkzaamheid en veiligheid","url":"https://hartvaat.nl/2026/02/01/factor-xi-xia-remmers-bij-atriumfibrilleren-dosisrespons-werkzaamheid-en-veiligh/","new":false},{"updated":"2026-08-10T11:07:51Z","type":"article","id":"8e26b95dda78","title":"Statinegebruik en invaliditeitsvrije overleving bij gezonde ouderen","url":"https://hartvaat.nl/2020/07/07/statinegebruik-en-invaliditeitsvrije-overleving-bij-gezonde-ouderen/","new":false},{"updated":"2026-08-10T11:07:50Z","type":"article","id":"18bd191ef755","title":"Cardiale amyloïdose komt frequent voor bij HFpEF, aortastenose en LVH — meta-analyse","url":"https://hartvaat.nl/2026/06/22/cardiale-amyloidose-komt-frequent-voor-bij-hfpef-aortastenose-en-lvh-meta-analys/","new":true},{"updated":"2026-08-10T10:38:33Z","type":"article","id":"e7e2d978241f","title":"Inflammatie als risicofactor krijgt onvoldoende ruimte in de ASCVD- en CKD-praktijk — SPARK-CVD","url":"https://hartvaat.nl/2026/09/01/inflammatie-als-risicofactor-krijgt-onvoldoende-ruimte-in-de-ascvd-en-ckd-prakti/","new":false},{"updated":"2026-08-10T10:38:30Z","type":"article","id":"f9ed467d9966","title":"Verhoogd Lp(a) gekoppeld aan ernstiger coronaire ziekte en PCI-uitkomsten — scoping review","url":"https://hartvaat.nl/2026/09/01/verhoogd-lp-a-gekoppeld-aan-ernstiger-coronaire-ziekte-en-pci-uitkomsten-scoping/","new":false},{"updated":"2026-08-10T10:38:28Z","type":"article","id":"068746c80bb8","title":"GLP-1-agonisten verlagen MACE en hartfalen-heropnames bij diabetes en ASCVD — meta-analyse","url":"https://hartvaat.nl/2026/09/01/glp-1-agonisten-verlagen-mace-en-hartfalen-heropnames-bij-diabetes-en-ascvd-meta/","new":false},{"updated":"2026-08-10T10:38:26Z","type":"article","id":"9998fea5a2e1","title":"TCL-biopsie tijdens carpaaltunneloperatie heeft lage diagnostische yield voor ATTR-CM","url":"https://hartvaat.nl/2026/09/01/tcl-biopsie-tijdens-carpaaltunneloperatie-heeft-lage-diagnostische-yield-voor-at/","new":false},{"updated":"2026-08-10T10:38:24Z","type":"article","id":"96b2f1ea737c","title":"Rusteloze benen en slaapbewegingen bepalen lipidenprofiel bij slaapapneu","url":"https://hartvaat.nl/2026/10/01/rusteloze-benen-en-slaapbewegingen-bepalen-lipidenprofiel-bij-slaapapneu/","new":false},{"updated":"2026-08-10T10:38:23Z","type":"article","id":"b229eef7de1a","title":"CPAP-therapie verlaagt diastolische bloeddruk bij niet-slaapige OSA — systematische review","url":"https://hartvaat.nl/2026/10/01/cpap-therapie-verlaagt-diastolische-bloeddruk-bij-niet-slaapige-osa-systematisch/","new":false},{"updated":"2026-08-10T10:38:19Z","type":"article","id":"6d3dfde1d0df","title":"RNA-remmers verlagen Lp(a) en triglyceriden bij residual risico — scoping review","url":"https://hartvaat.nl/2026/05/29/rna-remmers-verlagen-lp-a-en-triglyceriden-bij-residual-risico-scoping-review/","new":false},{"updated":"2026-08-10T10:38:17Z","type":"article","id":"d67dd979b398","title":"Lichaamsrondheidsindex (BRI) voorspelt sterfte bij nierpatiënten beter dan BMI","url":"https://hartvaat.nl/2026/05/29/lichaamsrondheidsindex-bri-voorspelt-sterfte-bij-nierpatienten-beter-dan-bmi/","new":false},{"updated":"2026-08-10T10:38:16Z","type":"article","id":"003091226ae3","title":"Cardiovasculaire ziekte blijft leidend na niertransplantatie — overzicht van uitdagingen en nieuwe therapieën","url":"https://hartvaat.nl/2026/05/29/cardiovasculaire-ziekte-blijft-leidend-na-niertransplantatie-overzicht-van-uitda/","new":false},{"updated":"2026-08-10T10:38:13Z","type":"article","id":"78b504a8eab6","title":"Atriumfibrilleren en hartfalen versterken elkaar en verhogen sterfte aanzienlijk — UK Biobank","url":"https://hartvaat.nl/2026/05/28/atriumfibrilleren-en-hartfalen-versterken-elkaar-en-verhogen-sterfte-aanzienlijk/","new":false},{"updated":"2026-08-10T10:38:12Z","type":"article","id":"c6cd95c27493","title":"Cardiotoxiciteit van HER2-remmers en multikinaseremmers — mechanismen en klinisch beleid","url":"https://hartvaat.nl/2026/05/27/cardiotoxiciteit-van-her2-remmers-en-multikinaseremmers-mechanismen-en-klinisch-/","new":false},{"updated":"2026-08-10T10:38:10Z","type":"article","id":"243209fb9ed1","title":"Inflammatoire biomarkers verbeteren risicostratificatie bij perifeer arterieel vaatlijden","url":"https://hartvaat.nl/2026/05/27/inflammatoire-biomarkers-verbeteren-risicostratificatie-bij-perifeer-arterieel-v/","new":false},{"updated":"2026-08-10T10:38:08Z","type":"article","id":"3d875fa878f5","title":"Multimodale beeldvorming verheldert atriumfibrilleren bij infiltratieve cardiomyopathieën","url":"https://hartvaat.nl/2026/05/25/multimodale-beeldvorming-verheldert-atriumfibrilleren-bij-infiltratieve-cardiomy/","new":false},{"updated":"2026-08-10T10:38:06Z","type":"article","id":"11711d232ef9","title":"Verhoogde albuminurie drijft hypercholesterolemie bij patiënten met het syndroom van Alport","url":"https://hartvaat.nl/2026/05/15/verhoogde-albuminurie-drijft-hypercholesterolemie-bij-patienten-met-het-syndroom/","new":false},{"updated":"2026-08-10T10:38:04Z","type":"article","id":"ac0e7e11488f","title":"Matige koffiedrinken waarschijnlijk veilig en mogelijk gunstig bij chronische nierziekte","url":"https://hartvaat.nl/2026/05/12/matige-koffiedrinken-waarschijnlijk-veilig-en-mogelijk-gunstig-bij-chronische-ni/","new":false},{"updated":"2026-08-10T10:38:03Z","type":"article","id":"d27b8a1b9f81","title":"Vereenvoudigde linkervoorhoofdaanhangsel-occlusie onder fluoroscopie met WATCHMAN FLX is veilig en haalbaar","url":"https://hartvaat.nl/2026/05/06/vereenvoudigde-linkervoorhoofdaanhangsel-occlusie-onder-fluoroscopie-met-watchma/","new":false},{"updated":"2026-08-10T10:38:01Z","type":"article","id":"ce13ed16e358","title":"Transseptale punctie bij linkshartinterventies: nieuwe ESC-consensus over techniek, beeldvorming en complicaties","url":"https://hartvaat.nl/2026/05/06/transseptale-punctie-bij-linkshartinterventies-nieuwe-esc-consensus-over-technie/","new":false},{"updated":"2026-08-10T10:38:00Z","type":"article","id":"d80f9a43525a","title":"Vroege harttoxiciteit na doxorubicine bij jongvolwassenen met sarcoom","url":"https://hartvaat.nl/2026/05/05/vroege-harttoxiciteit-na-doxorubicine-bij-jongvolwassenen-met-sarcoom/","new":false},{"updated":"2026-08-10T10:37:58Z","type":"article","id":"1a11e66a9fd5","title":"Sterftecijfers in controle-armen van hartfalen-RCTs dalen niet ondanks betere achtergrondtherapie","url":"https://hartvaat.nl/2026/05/05/sterftecijfers-in-controle-armen-van-hartfalen-rcts-dalen-niet-ondanks-betere-ac/","new":false},{"updated":"2026-08-10T10:37:56Z","type":"article","id":"244cb94326af","title":"Harttransplantatie bij hoogste urgentie: meer vroege infecties en sterfte, mede door langdurige beademing","url":"https://hartvaat.nl/2026/05/05/harttransplantatie-bij-hoogste-urgentie-meer-vroege-infecties-en-sterfte-mede-do/","new":false},{"updated":"2026-08-10T10:37:54Z","type":"article","id":"50161c2d7226","title":"CMR-parameters voorspellen nieuwe hartklachten bij hypertrofische cardiomyopathie","url":"https://hartvaat.nl/2026/05/05/cmr-parameters-voorspellen-nieuwe-hartklachten-bij-hypertrofische-cardiomyopathi/","new":false},{"updated":"2026-08-10T10:37:52Z","type":"article","id":"55792f40b6a1","title":"APTURE-shunt verlaagt hartfalen-heropnames bij patiënten met HFpEF/HFmrEF — ALT-FLOW","url":"https://hartvaat.nl/2026/05/05/apture-shunt-verlaagt-hartfalen-heropnames-bij-patienten-met-hfpef-hfmref-alt-fl/","new":false},{"updated":"2026-08-10T10:37:50Z","type":"article","id":"ae5014faccd5","title":"Off-label dosering van sacubitril-valsartan wijdverspreid in de praktijk","url":"https://hartvaat.nl/2026/05/05/off-label-dosering-van-sacubitril-valsartan-wijdverspreid-in-de-praktijk/","new":false},{"updated":"2026-08-10T10:37:49Z","type":"article","id":"fc88f977c403","title":"LVAD-beheer in de ICU — praktische richtlijnen voor intensivisten","url":"https://hartvaat.nl/2026/09/01/lvad-beheer-in-de-icu-praktische-richtlijnen-voor-intensivisten/","new":false},{"updated":"2026-08-10T10:37:47Z","type":"article","id":"af930377e4c8","title":"LVAD-patiënten op de intensive care: richtlijnen voor monitoring en acute zorg","url":"https://hartvaat.nl/2026/09/01/lvad-patienten-op-de-intensive-care-richtlijnen-voor-monitoring-en-acute-zorg/","new":false},{"updated":"2026-08-10T10:37:45Z","type":"article","id":"f5d7d5148d3e","title":"Langdurige LVAD-behandeling: klinisch beheer en uitkomsten in de HeartMate 3-eratie","url":"https://hartvaat.nl/2026/09/01/langdurige-lvad-behandeling-klinisch-beheer-en-uitkomsten-in-de-heartmate-3-erat/","new":false},{"updated":"2026-08-10T10:37:43Z","type":"article","id":"426c7104af7b","title":"Perifere zuurstofextractie bepaalt belasting bij arrhythmogene cardiomyopathie — fysiologisch pleidooi voor veilige training","url":"https://hartvaat.nl/2026/05/05/perifere-zuurstofextractie-bepaalt-belasting-bij-arrhythmogene-cardiomyopathie-f/","new":false},{"updated":"2026-08-10T10:37:40Z","type":"article","id":"4594c10f7bc6","title":"Grote variatie in diureticabeleid en zeldzame natriummeting bij acuut hartfalen","url":"https://hartvaat.nl/2026/05/05/grote-variatie-in-diureticabeleid-en-zeldzame-natriummeting-bij-acuut-hartfalen/","new":false},{"updated":"2026-08-10T10:37:38Z","type":"article","id":"f5b64801b43d","title":"Cardioselectieve bètablokkers veilig en nuttig bij COPD — systematische review","url":"https://hartvaat.nl/2026/05/01/cardioselectieve-betablokkers-veilig-en-nuttig-bij-copd-systematische-review/","new":false},{"updated":"2026-08-10T10:37:37Z","type":"article","id":"e38f4be89867","title":"INR-zelftest verbetert TTR en vermindert bloedingen bij patiënten met atriumfibrilleren","url":"https://hartvaat.nl/2026/05/01/inr-zelftest-verbetert-ttr-en-vermindert-bloedingen-bij-patienten-met-atriumfibr/","new":false},{"updated":"2026-08-10T10:37:35Z","type":"article","id":"88c6340765d6","title":"SPECT en cMRI bij ATTR-cardiomyopathie: beeldvorming toont beperkte segmentale nauwkeurigheid","url":"https://hartvaat.nl/2026/05/01/spect-en-cmri-bij-attr-cardiomyopathie-beeldvorming-toont-beperkte-segmentale-na/","new":false},{"updated":"2026-08-10T10:37:33Z","type":"article","id":"3f9c28fa47f0","title":"Erectiestoornis komt bij twee op drie hypertensieve mannen voor in Afrika — meta-analyse","url":"https://hartvaat.nl/2026/06/30/erectiestoornis-komt-bij-twee-op-drie-hypertensieve-mannen-voor-in-afrika-meta-a/","new":false},{"updated":"2026-08-10T10:37:32Z","type":"article","id":"90dab6e81d67","title":"SGLT2-remmers breiden indicatie uit naar niet-diabetische nier- en hartfalenziekte","url":"https://hartvaat.nl/2026/06/30/sglt2-remmers-breiden-indicatie-uit-naar-niet-diabetische-nier-en-hartfalenziekt/","new":false},{"updated":"2026-08-10T10:37:30Z","type":"article","id":"bb744356ec2b","title":"Hydrocortison verhoogt sterfte en cardiorenale uitkomsten bij CKD met septische shock","url":"https://hartvaat.nl/2026/09/01/hydrocortison-verhoogt-sterfte-en-cardiorenale-uitkomsten-bij-ckd-met-septische-/","new":false},{"updated":"2026-08-10T10:37:28Z","type":"article","id":"9fbe8a4a3dfb","title":"Combinatie GLP-1RA en SGLT2-remmer verlaagt hartritmestoornissen bij niet-diabetische obese patiënten","url":"https://hartvaat.nl/2026/09/01/combinatie-glp-1ra-en-sglt2-remmer-verlaagt-hartritmestoornissen-bij-niet-diabet/","new":false},{"updated":"2026-08-10T10:37:26Z","type":"article","id":"8ad4fb7c69aa","title":"Verhoogde Lp(a) komt vaker voor bij kinderen met familiaire hypercholesterolemie — systematische review","url":"https://hartvaat.nl/2026/08/01/verhoogde-lp-a-komt-vaker-voor-bij-kinderen-met-familiaire-hypercholesterolemie-/","new":false},{"updated":"2026-08-10T10:37:25Z","type":"article","id":"eeadffe8a0fc","title":"Combinatietherapie met vier pilaren verlaagt nierfalenrisico bij CKD","url":"https://hartvaat.nl/2026/06/30/combinatietherapie-met-vier-pilaren-verlaagt-nierfalenrisico-bij-ckd/","new":false},{"updated":"2026-08-10T10:37:23Z","type":"article","id":"5f8aac4918f6","title":"Icodextrin verlaagt sterfte en MACE bij dialysepatiënten met hartfalen","url":"https://hartvaat.nl/2026/06/30/icodextrin-verlaagt-sterfte-en-mace-bij-dialysepatienten-met-hartfalen/","new":false},{"updated":"2026-08-10T10:37:21Z","type":"article","id":"15bddfa879bf","title":"KFRE aangepast voor multimorbiditeit verbetert schatting nierfalenrisico","url":"https://hartvaat.nl/2026/06/30/kfre-aangepast-voor-multimorbiditeit-verbetert-schatting-nierfalenrisico/","new":false},{"updated":"2026-08-10T10:37:19Z","type":"article","id":"a1a918e17576","title":"Nieuwe universele definitie van hartfalen vervangt vaste EF-cutoffs door verbeterde, behouden en verminderde fenotypes","url":"https://hartvaat.nl/2026/06/29/nieuwe-universele-definitie-van-hartfalen-vervangt-vaste-ef-cutoffs-door-verbete/","new":false},{"updated":"2026-08-10T10:37:18Z","type":"article","id":"10b3c25ae044","title":"Cryoballoonablatie resulteert in meer linkeratrium-uitzetting dan radiofrequente ablatie na longaderisolatie","url":"https://hartvaat.nl/2026/06/28/cryoballoonablatie-resulteert-in-meer-linkeratrium-uitzetting-dan-radiofrequente/","new":false},{"updated":"2026-08-10T10:37:16Z","type":"article","id":"b968467af98f","title":"OAC-monotherapie is superieur aan combinatie met antiplatelets bij stabiele CCS en atriumfibrilleren","url":"https://hartvaat.nl/2026/06/27/oac-monotherapie-is-superieur-aan-combinatie-met-antiplatelets-bij-stabiele-ccs-/","new":false},{"updated":"2026-08-10T10:37:14Z","type":"article","id":"b0db95a8ccc3","title":"Lipoproteïne-afseparatie bij refractaire FH en Lp(a) — verschuivende rol naar vaat- en nierziekten","url":"https://hartvaat.nl/2026/08/01/lipoproteine-afseparatie-bij-refractaire-fh-en-lp-a-verschuivende-rol-naar-vaat-/","new":false},{"updated":"2026-08-10T10:37:13Z","type":"article","id":"f2570a7cdb9e","title":"Hartfalen als belangrijkste risicofactor voor amyloidose bij carpaaltunnelsyndroom","url":"https://hartvaat.nl/2026/05/01/hartfalen-als-belangrijkste-risicofactor-voor-amyloidose-bij-carpaaltunnelsyndro/","new":false},{"updated":"2026-08-10T10:37:11Z","type":"article","id":"9911af4b1d4a","title":"Infectieuze endocarditis: verschuiving naar oudere patiënten met comorbiditeiten en medische hulpmiddelen","url":"https://hartvaat.nl/2026/06/30/infectieuze-endocarditis-verschuiving-naar-oudere-patienten-met-comorbiditeiten-/","new":false},{"updated":"2026-08-10T10:37:09Z","type":"article","id":"4b2681c4afc1","title":"Familiaire hypercholesterolemie en hypertriglyceridemie: nieuw diagnostisch algoritme combineert genetica, ApoB en Lp(a)","url":"https://hartvaat.nl/2026/06/29/familiaire-hypercholesterolemie-en-hypertriglyceridemie-nieuw-diagnostisch-algor/","new":false},{"updated":"2026-08-10T10:37:07Z","type":"article","id":"eba2370ffd2a","title":"TAVR bij patiënten ≤65 jaar: hogere sterfte en heropnames dan chirurgie, maar onvoldoende bewijs — overzicht","url":"https://hartvaat.nl/2026/06/27/tavr-bij-patienten-65-jaar-hogere-sterfte-en-heropnames-dan-chirurgie-maar-onvol/","new":false},{"updated":"2026-08-10T10:37:06Z","type":"article","id":"659193548e64","title":"Frailte versnelt hartfalenprogressie en vermindert therapietolerantie","url":"https://hartvaat.nl/2026/06/27/frailte-versnelt-hartfalenprogressie-en-vermindert-therapietolerantie/","new":false},{"updated":"2026-08-10T10:37:04Z","type":"article","id":"ef5c63a10afb","title":"Menopauze en cardiovasculaire veroudering: preventiekansen in de middenleeftijd","url":"https://hartvaat.nl/2026/09/01/menopauze-en-cardiovasculaire-veroudering-preventiekansen-in-de-middenleeftijd/","new":true},{"updated":"2026-08-10T10:37:03Z","type":"article","id":"95d07304f716","title":"Hogere ziekenhuisvolumes verbeteren efficiëntie bij transcarotide TAVR — maar mortaliteit blijft gelijk","url":"https://hartvaat.nl/2026/09/01/hogere-ziekenhuisvolumes-verbeteren-efficientie-bij-transcarotide-tavr-maar-mort/","new":true},{"updated":"2026-08-10T10:37:01Z","type":"article","id":"7d7562a57093","title":"Dapagliflozin kosteneffectief bij chronisch hartfalen — economische evaluatie in Argentinië","url":"https://hartvaat.nl/2026/10/01/dapagliflozin-kosteneffectief-bij-chronisch-hartfalen-economische-evaluatie-in-a/","new":true},{"updated":"2026-08-10T10:36:59Z","type":"article","id":"551c740a1134","title":"Functioneel nierreservoir als aanvulling op KDIGO-CGA bij chronische nierziekte","url":"https://hartvaat.nl/2026/06/29/functioneel-nierreservoir-als-aanvulling-op-kdigo-cga-bij-chronische-nierziekte/","new":true},{"updated":"2026-08-10T10:36:57Z","type":"article","id":"172253cf7b60","title":"Laag cachexie-index voorspelt overleving en heropname bij hartfalenpatiënten","url":"https://hartvaat.nl/2026/06/27/laag-cachexie-index-voorspelt-overleving-en-heropname-bij-hartfalenpatienten/","new":true},{"updated":"2026-08-10T10:36:55Z","type":"article","id":"ff8acaccc32f","title":"Correctie van LDL-C voor lipoproteïne(a) verbetert diagnose familiaire hypercholesterolemie","url":"https://hartvaat.nl/2026/06/26/correctie-van-ldl-c-voor-lipoproteine-a-verbetert-diagnose-familiaire-hyperchole/","new":true},{"updated":"2026-08-10T10:36:54Z","type":"article","id":"9098f972e08b","title":"SGLT2-remmers kunnen hyperkaliëmie-gerelateerd stoppen van RAAS-remmers voorkomen bij MRA-gebruik","url":"https://hartvaat.nl/2026/06/26/sglt2-remmers-kunnen-hyperkaliemie-gerelateerd-stoppen-van-raas-remmers-voorkome/","new":true},{"updated":"2026-08-10T10:36:52Z","type":"article","id":"0638ff453ccc","title":"Peptidehormooncombinaties bieden superieure effectiviteit bij metabole multimorbiditeit","url":"https://hartvaat.nl/2026/06/26/peptidehormooncombinaties-bieden-superieure-effectiviteit-bij-metabole-multimorb/","new":true},{"updated":"2026-08-10T10:36:50Z","type":"article","id":"37d67c5c974c","title":"Finerenone verlaagt hart- en vaatrisico via vroege daling van UACR en systolische bloeddruk — FIDELITY-analyse","url":"https://hartvaat.nl/2026/06/26/finerenone-verlaagt-hart-en-vaatrisico-via-vroege-daling-van-uacr-en-systolische/","new":true},{"updated":"2026-08-10T10:36:49Z","type":"article","id":"e81cc95daa37","title":"Machine learning voorspelt diureticumrespons bij acuut hartfalen — DRC-AHF","url":"https://hartvaat.nl/2026/06/26/machine-learning-voorspelt-diureticumrespons-bij-acuut-hartfalen-drc-ahf/","new":true},{"updated":"2026-08-10T10:36:47Z","type":"article","id":"1c84a3a24334","title":"SGLT2-remmers, GLP-1-agonisten en finerenone voor nierbescherming bij type 1-diabetes","url":"https://hartvaat.nl/2026/09/01/sglt2-remmers-glp-1-agonisten-en-finerenone-voor-nierbescherming-bij-type-1-diab/","new":true},{"updated":"2026-08-10T10:36:45Z","type":"article","id":"a3b9d306fc8a","title":"Cardiorenale risico’s bij type 1-diabetes — een overzicht van de huidige stand van zaken","url":"https://hartvaat.nl/2026/09/01/cardiorenale-risicos-bij-type-1-diabetes-een-overzicht-van-de-huidige-stand-van-/","new":true},{"updated":"2026-08-10T10:36:43Z","type":"article","id":"96c77cc79366","title":"Naast insuline zijn nieuwe medicijnen nodig om het hart- en vaatrisico bij type 1-diabetes te verlagen","url":"https://hartvaat.nl/2026/09/01/naast-insuline-zijn-nieuwe-medicijnen-nodig-om-het-hart-en-vaatrisico-bij-type-1/","new":true},{"updated":"2026-08-10T10:36:41Z","type":"article","id":"82c0179fd940","title":"Cardiorenale bescherming door SGLT2-remmers, GLP-1-agonisten en MRA's bij type 1-diabetes","url":"https://hartvaat.nl/2026/09/01/cardiorenale-bescherming-door-sglt2-remmers-glp-1-agonisten-en-mra-s-bij-type-1-/","new":true},{"updated":"2026-08-10T10:36:40Z","type":"article","id":"b90eb3d21c41","title":"ICE-gestuurde LAAC toont lage stroke- en bloedingsrisico’s op lange termijn","url":"https://hartvaat.nl/2026/10/15/ice-gestuurde-laac-toont-lage-stroke-en-bloedingsrisicos-op-lange-termijn/","new":true},{"updated":"2026-08-10T10:36:38Z","type":"article","id":"6ffec8564847","title":"Lage voorspelde adherentie verhoogt stroke-risico bij AF-patiënten die starten met orale anticoagulatie","url":"https://hartvaat.nl/2026/10/15/lage-voorspelde-adherentie-verhoogt-stroke-risico-bij-af-patienten-die-starten-m/","new":true},{"updated":"2026-08-10T10:36:37Z","type":"article","id":"bb315e578da1","title":"Parodontitis kan via systemische ontsteking bijdragen aan hartfalen — narratieve review","url":"https://hartvaat.nl/2026/10/01/parodontitis-kan-via-systemische-ontsteking-bijdragen-aan-hartfalen-narratieve-r/","new":true},{"updated":"2026-08-10T10:36:35Z","type":"article","id":"92cbe1082232","title":"SGLT2-remmers en bloeddrukdoelen bij hypertensief HFpEF — een overzicht van richtlijnen en bewijs","url":"https://hartvaat.nl/2026/06/24/sglt2-remmers-en-bloeddrukdoelen-bij-hypertensief-hfpef-een-overzicht-van-richtl/","new":true},{"updated":"2026-08-10T10:36:33Z","type":"article","id":"2f27d43301c1","title":"VExUS-scoring biedt completer beeld van congestie bij hartfalen","url":"https://hartvaat.nl/2026/06/24/vexus-scoring-biedt-completer-beeld-van-congestie-bij-hartfalen/","new":true},{"updated":"2026-08-10T10:36:31Z","type":"article","id":"de2d080bcdfe","title":"Meer kip dan rundvlees of vis bij avondmaaltijd gekoppeld aan grotere bloeddrukdaling — MED-HDP","url":"https://hartvaat.nl/2026/06/24/meer-kip-dan-rundvlees-of-vis-bij-avondmaaltijd-gekoppeld-aan-grotere-bloeddrukd/","new":true},{"updated":"2026-08-10T10:36:29Z","type":"article","id":"f6015b144b7a","title":"Inclisiran als monotherapie verlaagt LDL-C met 47,5% in Chinese volwassenen — VICTORION-Mono","url":"https://hartvaat.nl/2026/06/26/inclisiran-als-monotherapie-verlaagt-ldl-c-met-47-5-in-chinese-volwassenen-victo/","new":true},{"updated":"2026-08-10T10:36:27Z","type":"article","id":"b5cf84598dd8","title":"VLDL en HDL-tg verhoogd bij overgewicht bij kinderen — geavanceerd lipoproteïneprofiel toont extra informatie","url":"https://hartvaat.nl/2026/06/23/vldl-en-hdl-tg-verhoogd-bij-overgewicht-bij-kinderen-geavanceerd-lipoproteinepro/","new":true},{"updated":"2026-08-10T10:36:25Z","type":"article","id":"818c83788913","title":"rhBNP-therapie vermindert congestie en dyspnoe bij rechterhartfalen door longhypertensie","url":"https://hartvaat.nl/2026/06/23/rhbnp-therapie-vermindert-congestie-en-dyspnoe-bij-rechterhartfalen-door-longhyp/","new":true},{"updated":"2026-08-10T10:36:24Z","type":"article","id":"7abceeb0c198","title":"Lifestyle-modificatie en metabole therapieën bij cardiometabole HFpEF — overzicht","url":"https://hartvaat.nl/2026/06/23/lifestyle-modificatie-en-metabole-therapieen-bij-cardiometabole-hfpef-overzicht/","new":true},{"updated":"2026-08-10T10:36:22Z","type":"article","id":"3edc8ae0829a","title":"Zwangerschapsgeassocieerd acuut nierfalen: pathofysiologie en verhoogd langetermijnrisico op hart- en vaatziekten","url":"https://hartvaat.nl/2026/06/23/zwangerschapsgeassocieerd-acuut-nierfalen-pathofysiologie-en-verhoogd-langetermi/","new":true},{"updated":"2026-08-10T10:36:18Z","type":"article","id":"81792b922e62","title":"Vrouwen met CKD krijgen minder vaak RAS-remmers en SGLT2-remmers dan mannen","url":"https://hartvaat.nl/2026/06/19/vrouwen-met-ckd-krijgen-minder-vaak-ras-remmers-en-sglt2-remmers-dan-mannen/","new":true},{"updated":"2026-08-10T10:36:16Z","type":"article","id":"38beb9b2c5d7","title":"Rivaroxaban verlaagt DVT-risico na gewrichtsvervanging, maar verhoogt bloedingen","url":"https://hartvaat.nl/2026/06/16/rivaroxaban-verlaagt-dvt-risico-na-gewrichtsvervanging-maar-verhoogt-bloedingen/","new":true},{"updated":"2026-08-10T10:36:14Z","type":"article","id":"2a21b430eaed","title":"ML-modellen voorspellen sterfte bij post-cardiotomisch shock op ECMO — ELSO-registry","url":"https://hartvaat.nl/2026/06/13/ml-modellen-voorspellen-sterfte-bij-post-cardiotomisch-shock-op-ecmo-elso-regist/","new":true},{"updated":"2026-08-10T10:36:13Z","type":"article","id":"1bf561be1fc9","title":"Longultrasongrafie onthult subklinische longcongestie bij stabiele HFpEF in de huisartspraktijk","url":"https://hartvaat.nl/2026/06/11/longultrasongrafie-onthult-subklinische-longcongestie-bij-stabiele-hfpef-in-de-h/","new":true},{"updated":"2026-08-10T10:36:11Z","type":"article","id":"35d3006b7e26","title":"Vutrisiran remt TTR en vermindert valrisico bij ATTR-cardiomyopathie — meta-analyse","url":"https://hartvaat.nl/2026/06/30/vutrisiran-remt-ttr-en-vermindert-valrisico-bij-attr-cardiomyopathie-meta-analys/","new":true},{"updated":"2026-08-10T10:36:09Z","type":"article","id":"2cabf36716d0","title":"Catheterablatie verlaagt sterfte en complicaties bij AF in cardiale amyloïdose — TriNetX-cohort","url":"https://hartvaat.nl/2026/06/30/catheterablatie-verlaagt-sterfte-en-complicaties-bij-af-in-cardiale-amyloidose-t/","new":true},{"updated":"2026-08-10T10:36:07Z","type":"article","id":"502ab223879c","title":"DOAC-gebruik na ablatie voor atriumfibrilleren: aanhouderij daalt na drie jaar","url":"https://hartvaat.nl/2026/06/02/doac-gebruik-na-ablatie-voor-atriumfibrilleren-aanhouderij-daalt-na-drie-jaar/","new":true},{"updated":"2026-08-10T10:36:05Z","type":"article","id":"de817b7f9e23","title":"Autonoom remodelling vormt onafhankelijk domein binnen atriale cardiomyopathie","url":"https://hartvaat.nl/2026/06/02/autonoom-remodelling-vormt-onafhankelijk-domein-binnen-atriale-cardiomyopathie/","new":true},{"updated":"2026-08-10T10:36:04Z","type":"article","id":"4e5431aaff01","title":"Catheterablatie bij atriumfibrilleren in cardiale amyloïdose levert 42% ritmievrije patiënten op — AMYL-AF","url":"https://hartvaat.nl/2026/06/02/catheterablatie-bij-atriumfibrilleren-in-cardiale-amyloidose-levert-42-ritmievri/","new":true},{"updated":"2026-08-10T10:36:02Z","type":"article","id":"c1c983b9212f","title":"Vroege katheterablatie even effectief als antiaritmica bij ischemische ventriculaire tachycardie — meta-analyse","url":"https://hartvaat.nl/2026/06/02/vroege-katheterablatie-even-effectief-als-antiaritmica-bij-ischemische-ventricul/","new":true},{"updated":"2026-08-10T10:36:00Z","type":"article","id":"b6125ec63bbc","title":"Pulsfield-ablatie levert betere vrijwaring van recidief dan cryoballoon bij paroxysmale AF — SINGLE SHOT CHAMPION","url":"https://hartvaat.nl/2026/06/02/pulsfield-ablatie-levert-betere-vrijwaring-van-recidief-dan-cryoballoon-bij-paro/","new":true},{"updated":"2026-08-10T10:35:58Z","type":"article","id":"ae54e79edc23","title":"Smartphone-app voor symptoomregistratie na ablatie bij atriumfibrilleren — ISOLATION","url":"https://hartvaat.nl/2026/06/02/smartphone-app-voor-symptoomregistratie-na-ablatie-bij-atriumfibrilleren-isolati/","new":true},{"updated":"2026-08-10T10:35:56Z","type":"article","id":"1ca9fcee22aa","title":"Oudere STEMI-patiënten hebben meer complicaties en hogere sterfte dan jongeren — een prospectieve cohortstudie","url":"https://hartvaat.nl/2026/06/01/oudere-stemi-patienten-hebben-meer-complicaties-en-hogere-sterfte-dan-jongeren-e/","new":true},{"updated":"2026-08-10T10:35:55Z","type":"article","id":"875ff3095acb","title":"VIS-score voorspelt 28-daagse mortaliteit bij atriumfibrilleren met hemodynamische instabiliteit op de IC","url":"https://hartvaat.nl/2026/06/01/vis-score-voorspelt-28-daagse-mortaliteit-bij-atriumfibrilleren-met-hemodynamisc/","new":true},{"updated":"2026-08-10T10:35:53Z","type":"article","id":"b8a020b8ef15","title":"Perioperatieve empagliflozin verlaagt trend postoperatieve boezemfibrilleren na klepsurgery — RCT","url":"https://hartvaat.nl/2026/09/01/perioperatieve-empagliflozin-verlaagt-trend-postoperatieve-boezemfibrilleren-na-/","new":true},{"updated":"2026-08-10T10:35:51Z","type":"article","id":"f8e6d9d54c0c","title":"TAVR met ballon-expanderbare klep heeft vergelijkbare overleving en minder complicaties dan chirurgische vervanging bij laag-risico aortastenose","url":"https://hartvaat.nl/2026/09/01/tavr-met-ballon-expanderbare-klep-heeft-vergelijkbare-overleving-en-minder-compl/","new":true},{"updated":"2026-08-10T10:35:49Z","type":"article","id":"bdcc8ad43963","title":"Cardiovasculair risico van ADT en ARPI's bij prostaatkanker — narrative review","url":"https://hartvaat.nl/2026/06/01/cardiovasculair-risico-van-adt-en-arpi-s-bij-prostaatkanker-narrative-review/","new":true},{"updated":"2026-08-10T10:35:47Z","type":"article","id":"56beb909698a","title":"GLP-1-polyagonisten verbeteren leverhistologie en vetgehalte bij MASLD/MASH — meta-analyse","url":"https://hartvaat.nl/2026/06/01/glp-1-polyagonisten-verbeteren-leverhistologie-en-vetgehalte-bij-masld-mash-meta/","new":true},{"updated":"2026-08-10T10:35:44Z","type":"article","id":"845e56618583","title":"GLP-1-agonisten verlagen MACE met 14% bij diabetes type 2 — meta-analyse","url":"https://hartvaat.nl/2026/06/01/glp-1-agonisten-verlagen-mace-met-14-bij-diabetes-type-2-meta-analyse/","new":true},{"updated":"2026-08-10T10:35:43Z","type":"article","id":"8b9b33cfaa5f","title":"Draagbare sensoren voor comorbiditeit OSA en hypertensie: huidige stand van zaken en beperkingen","url":"https://hartvaat.nl/2026/07/31/draagbare-sensoren-voor-comorbiditeit-osa-en-hypertensie-huidige-stand-van-zaken/","new":true},{"updated":"2026-08-10T10:35:41Z","type":"article","id":"0b18f02764cd","title":"Ontstekingsrijke voeding verhoogt sterfterisico bij CKM-syndroom — NHANES-cohort","url":"https://hartvaat.nl/2026/07/31/ontstekingsrijke-voeding-verhoogt-sterfterisico-bij-ckm-syndroom-nhanes-cohort/","new":true},{"updated":"2026-08-10T10:35:39Z","type":"article","id":"439079c1382f","title":"Hoge serumbicarbonaat bij opname voorspelt diuretische resistentie bij acute hartfalenexacerbatie","url":"https://hartvaat.nl/2026/07/31/hoge-serumbicarbonaat-bij-opname-voorspelt-diuretische-resistentie-bij-acute-har/","new":true},{"updated":"2026-08-10T10:35:37Z","type":"article","id":"af8ddedf3661","title":"Verhoogde serumketonen verlagen niercomplicaties bij type 2-diabetes — prospectief cohort","url":"https://hartvaat.nl/2026/07/31/verhoogde-serumketonen-verlagen-niercomplicaties-bij-type-2-diabetes-prospectief/","new":true},{"updated":"2026-08-10T10:35:35Z","type":"article","id":"fa09028359de","title":"Steilere eGFR-daling voorspelt nierfalen en cardiovasculaire mortaliteit — narratieve review","url":"https://hartvaat.nl/2026/07/31/steilere-egfr-daling-voorspelt-nierfalen-en-cardiovasculaire-mortaliteit-narrati/","new":true},{"updated":"2026-08-10T10:35:33Z","type":"article","id":"fce87e0996f7","title":"Drinkfrequentie bepaalt HDL-C-niveau meer dan hoeveelheid per keer — Tromsø-studie","url":"https://hartvaat.nl/2026/09/01/drinkfrequentie-bepaalt-hdl-c-niveau-meer-dan-hoeveelheid-per-keer-troms-studie/","new":true},{"updated":"2026-08-10T10:35:31Z","type":"article","id":"4392a5674782","title":"Biomarker-gestuurde farmacotherapie biedt raamwerk voor precisiebehandeling bij CKM-syndroom","url":"https://hartvaat.nl/2026/10/01/biomarker-gestuurde-farmacotherapie-biedt-raamwerk-voor-precisiebehandeling-bij-/","new":true},{"updated":"2026-08-10T10:35:30Z","type":"article","id":"117b2521339d","title":"SGLT2-remmers bij zeer oude hartfalenpatiënten: nierfunctie en palliatieve zorg bepalen voorschrijfpatroon","url":"https://hartvaat.nl/2026/10/01/sglt2-remmers-bij-zeer-oude-hartfalenpatienten-nierfunctie-en-palliatieve-zorg-b/","new":true},{"updated":"2026-08-10T10:35:28Z","type":"article","id":"ef47e9e07df9","title":"Atenolol vermindert postoperatief atriumfibrilleren na hartchirurgie","url":"https://hartvaat.nl/2026/07/31/atenolol-vermindert-postoperatief-atriumfibrilleren-na-hartchirurgie/","new":true},{"updated":"2026-08-10T10:35:26Z","type":"article","id":"1a5f2aeadce4","title":"15 mg edoxaban na PCI bij atriumfibrilleren met hoog bloedingrisico — geen superieure uitkomst","url":"https://hartvaat.nl/2026/07/31/15-mg-edoxaban-na-pci-bij-atriumfibrilleren-met-hoog-bloedingrisico-geen-superie/","new":true},{"updated":"2026-08-10T10:35:25Z","type":"article","id":"4e64612704b9","title":"Finerenone verhoogt complete nierremissie bij niet-diabetische IgA-nefropatie","url":"https://hartvaat.nl/2026/07/31/finerenone-verhoogt-complete-nierremissie-bij-niet-diabetische-iga-nefropatie/","new":true},{"updated":"2026-08-10T10:35:23Z","type":"article","id":"7af1ba3f5882","title":"Uit-het-hospitaal hartstilstand komt 12 keer vaker voor bij niet-ischemische cardiomyopathie — registerstudie","url":"https://hartvaat.nl/2026/07/31/uit-het-hospitaal-hartstilstand-komt-12-keer-vaker-voor-bij-niet-ischemische-car/","new":true},{"updated":"2026-08-10T10:35:22Z","type":"article","id":"26bd7b14c65f","title":"Visinname en visgerelateerde metabolieten geassocieerd met lagere triglyceriden en bloeddruk","url":"https://hartvaat.nl/2026/07/30/visinname-en-visgerelateerde-metabolieten-geassocieerd-met-lagere-triglyceriden-/","new":true},{"updated":"2026-08-10T10:35:20Z","type":"article","id":"e2f9f340a0e9","title":"HFpEF bij vrouwen vereist geslachtsspecifieke diagnostiek en behandelstrategieën","url":"https://hartvaat.nl/2026/07/30/hfpef-bij-vrouwen-vereist-geslachtsspecifieke-diagnostiek-en-behandelstrategieen/","new":true},{"updated":"2026-08-10T10:35:18Z","type":"article","id":"cfbc0b432c13","title":"VAD-implantatie bij enkelventrikelhart: overleving verbetert maar complicaties blijven frequent","url":"https://hartvaat.nl/2026/07/30/vad-implantatie-bij-enkelventrikelhart-overleving-verbetert-maar-complicaties-bl/","new":true},{"updated":"2026-08-10T03:37:21Z","type":"vacancy","id":"67ff0da3453d","title":"Echoscopist Gynaecologie/Verloskunde","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-10T03:37:21Z","type":"vacancy","id":"60c68735bc55","title":"Vacature — Medisch secretarieel medewerker cardiologie, aangeboren hartafwijkingen","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-10T03:37:20Z","type":"vacancy","id":"9a023a2d6fd6","title":"Vacature — Secretaresse Hartfalen en Harttransplantatie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-10T03:37:20Z","type":"vacancy","id":"b162c374277c","title":"Vacature — Verpleegkundige Interne, Longgeneeskunde en Cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-10T03:37:20Z","type":"vacancy","id":"ea1cdb1768a8","title":"Regieverpleegkundige cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-10T03:37:20Z","type":"vacancy","id":"cb03f665a6d0","title":"Vacature — Internist, met als aandachtsgebied vasculair geneeskunde (0,7fte)","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-10T03:37:20Z","type":"vacancy","id":"bc2ef8c77999","title":"Vacature — Vasculair diagnostisch laborant","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-08-10T03:37:19Z","type":"vacancy","id":"d883a8be5aba","title":"Kom werken als Algemeen hartfunctielaborant bij Noordwest","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-08-10T03:37:18Z","type":"vacancy","id":"b4010476b454","title":"Kom werken als Hartfunctielaborant interventiecardiologie bij Noordwest","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-08-10T03:37:17Z","type":"vacancy","id":"a3d6f617691b","title":"Planner Hartbewaking","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-10T03:37:17Z","type":"vacancy","id":"fa5f8221e733","title":"Doktersassistent poli Cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-10T03:37:16Z","type":"vacancy","id":"f1e1b3307fec","title":"Doseeradviseur trombosezorg","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-10T03:37:16Z","type":"vacancy","id":"94c67d87a298","title":"Cardiac Care (CCU) verpleegkundige in opleiding","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-10T03:37:16Z","type":"vacancy","id":"d6bd412f7d37","title":"Cardiac Care (CCU) verpleegkundige","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-05T04:17:12Z","type":"podcastepisode","id":"60257","title":"What’s the story with mRNA vaccines?","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-08-05T04:17:10Z","type":"podcastepisode","id":"60256","title":"#45: Van hoogbegaafdheid tot vaatgezondheid","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-08-03T03:33:57Z","type":"vacancy","id":"1a07c6999a92","title":"Vacature — Medewerker interventiecardiologie in opleiding","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-08-03T03:33:54Z","type":"vacancy","id":"d2290b529d8f","title":"Dialyseverpleegkundige in opleiding met ziekenhuiservaring","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-03T03:33:54Z","type":"vacancy","id":"addad9e893c1","title":"Dialyseverpleegkundige in opleiding","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-03T03:33:54Z","type":"vacancy","id":"4b5b7fe6a339","title":"Vacature: Doktersassistent Nefrologie en Niertransplantatie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-03T03:33:53Z","type":"vacancy","id":"26b4c5b4ae2c","title":"Dialyseverpleegkundige","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-03T03:33:53Z","type":"vacancy","id":"084554f306b6","title":"Medisch maatschappelijk werker Dialysecentrum","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-08-03T03:33:52Z","type":"vacancy","id":"dac890338552","title":"Werken binnen het St. Antonius Hartcentrum I Cardiologie","url":"https://hartvaat.nl/vacatures/","new":false}]}